Jan 29 2025
A new study published in Drug Design, Development and Therapy suggests that cannabidiol (CBD) may help protect the heart from damage caused by the chemotherapy drug doxorubicin (DOX) by activating the Hippo signaling pathway. DOX is widely used to treat cancer but is known for its cardiotoxic effects. While previous research has indicated that CBD …
Jan 27 2025
Cannabis’ chemical diversity and its potential as a multi-target treatment for Alzheimer’s disease (AD) are at the center of a new review published in IBRO Neuroscience Reports. The review categorizes the compounds found in cannabis into cannabinoids and non-cannabinoids, exploring their roles in combating AD-related pathological features. With AD’s complexity often rendering single-target therapies insufficient, …
Jan 25 2025
Researchers from the University of Michigan have conducted a feasibility pilot study on a novel coaching intervention aimed at helping Veterans optimize their use of medical cannabis products for managing chronic pain. The study, published in the Journal of Cannabis Research and available online via the U.S. National Library of Medicine, involved Veterans with chronic …
Jan 24 2025
Cannabigerol (CBG), a cannabis compound, may help to treat atopic dermatitis (AD), according to a study published in the journal Cells. Researchers from the Catholic University of Korea used both cellular and mouse models of AD to evaluate the therapeutic effects of CBG. The findings revealed significant reductions in inflammation and improvements in skin health. …
Jan 22 2025
A new study published in the peer-reviewed journal Muscle & Nerve shows that full-spectrum cannabidiol (CBD) oil may help treat Duchenne muscular dystrophy (DMD). Conducted by researchers at the Federal University of Alfenas in Brazil, the study focused on both in vitro and in vivo models, using an animal model. “Duchenne muscular dystrophy (DMD) is …
Jan 21 2025
A recent study by researchers from The University of British Columbia introduces the Index of Cannabis Equivalence (ICE), a user-centered approach aimed at standardizing cannabis doses across various modes of consumption. The study, published by the Journal of Psychoactive Drugs, involved 1,368 participants aged 18 to 93, with a mean age of 31.6 years, and …
Jan 21 2025
A study conducted by researchers from Yozgat Bozok University Faculty of Medicine and Kırıkkale University Faculty of Medicine explored cannabidiol (CBD) as a possible treatment for cadmium-induced toxicity. Current chelation therapies for cadmium poisoning are associated with severe side effects, prompting interest in safer alternatives. The research involved four groups of mice, with groups II …
Jan 17 2025
A recent Harris Poll survey conducted for Green Thumb Industries’ incredibles brand reveals that sleep difficulties impact nearly 79% of adults age 21 and older. The survey highlights a growing trend of using cannabis as a sleep aid, with 16% of adults turning to marijuana—more than those who use prescription sleep aids (12%) or alcohol …
Jan 14 2025
A study by researchers from Oregon State University and Washington State University has found that high-potency cannabis may improve mood and decrease anxiety in young adults, while having no affects on emotional regulation. Published in Human Psychopharmacology: Clinical & Experimental, the study “used a novel methodology to examine the acute effects of high-potency cannabis flower …
Jan 13 2025
A study published in the Journal of Inflammation Research reveals that cannabidiol (CBD) has therapeutic potential for combatting intestinal fibrosis in ulcerative colitis. For the study, researchers from Jiamusi University, Tianjin First Central Hospital, and Nankai University in China investigated the effects of CBD on in an animal model, utilizing various techniques such as enzyme-linked …
